Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2005
03/17/2005US20050059803 Oligonucleotide probe for use in detection of phosphatidyl inositol 3 kinase expression; fungicides; antitumor agents
03/17/2005US20050059801 Transmembrane receptor/chemokine receptor for use in identifying modulators for treatment of glomerulonephritis, asthma, inflammatory bowel, transplant rejection and inflammation
03/17/2005US20050059630 TTK in diagnosis and as a therapeutic target in cancer
03/17/2005US20050059628 Modulation of beta-catenin/TCF-activated transcription
03/17/2005US20050059625 Immunostimulatory nucleic acid molecules
03/17/2005US20050059619 Immunostimulatory nucleic acids
03/17/2005US20050059618 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
03/17/2005US20050059575 Assays
03/17/2005US20050059158 Determining concentration of preferential particles in solution via fluorescent excitation; fluorescent semiconductor elements
03/17/2005US20050059156 Detecting presence of organic chemical contaminant in an anthracycline product via chromatographic separation and DNA elution
03/17/2005US20050059147 Human mesenchymal progenitor cell
03/17/2005US20050059126 Engineered enzymes comprised of protein scaffold and specificity determining regions; fusion proteins, nucleic acid molecules, vectors, host cells
03/17/2005US20050059123 Using allelic variation to differentiate animal products on basis of breed origin
03/17/2005US20050059120 Using allergen induced cytokines as tool in diagnosing inflammatory bowel disease
03/17/2005US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents
03/17/2005US20050059115 Using biglycan protein to diagnose, prevent and treatment of cell proliferative disorders
03/17/2005US20050059109 Methods and compositions for polypeptide engineering
03/17/2005US20050059108 Expression vector comprising nucleotide sequences coding neurotransmitter for use in prevention and treatment of obesity, anorexia, energy imbalance, diabetes, dyslipidemia, hypertension and/or insulin resistance
03/17/2005US20050059106 Antisense oligonucleotide for use in controlling genes associated with carbon regulationin bacteria; prevention of infection; bactericides
03/17/2005US20050059105 Impedimetric biosensor and its use for rapid detection of bacterial pathogens in solution
03/17/2005US20050059100 For detecting and analyzing oxidized polypeptides, nucleic acids, lipids, and polysaccharides; kits; neurodegenerative/neoplastic/vascular/autoimmune disorders
03/17/2005US20050059097 Quantitative binding assays using green fluorescent protein as a label
03/17/2005US20050059095 Using random encoded array detection (READ) format as diagnostic tool in detection of multiple cell-surface and transmembrane proteins; disease diagnostic and drug screening
03/17/2005US20050059093 Method for detecting modulators of Notch signalling
03/17/2005US20050059092 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
03/17/2005US20050059089 Complexes of GPCR142 and relaxin3 or INSL5, and their production and use
03/17/2005US20050059085 Thermus transcriptional replicative protein for use in identifying modulator which inhibit bacterial growth; rational drug design and screening; bactericides
03/17/2005US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells
03/17/2005US20050059079 Expression vector comprising nucleotide sequences associated with neuropsychological disruption for use in diagnosis, prevention and treatment of schizophrenia, mood and bipolar disorders
03/17/2005US20050059078 Transgenic cells for use as bioreactors; heterologous gene expression; animal model of disease
03/17/2005US20050059077 Identifying secondary reulatory sites associated with telomerase expression for use as tools in treatment and prevention of aging, cell proliferative and nervous system disorders
03/17/2005US20050059071 Diagnosing age related and cardiovascular disorders using variation in lamin a gene expression profiles
03/17/2005US20050059070 Human single nucleotide polymorphisms in ION channels and other proteins
03/17/2005US20050059069 Stable hybrid
03/17/2005US20050059067 Using restriction fragment length polymorphism in tyrosine kinase varian t as diagnostic tool in detection of cell proliferative and inflammatory disorders
03/17/2005US20050059065 Solid phase support for use in genomic analysis; gene expression analysis; high throughput assay; genotyping
03/17/2005US20050059064 Nucleotide sequences for use as probes in identifying gene sequences associated with vancomycin resistance in gramnegative bacteria
03/17/2005US20050059063 Color-encoding and in-situ interrogation of matrix-coupled chemical compounds
03/17/2005US20050059062 Enhanced optical readers or scanners for detecting emissions from biological probe arrays; gene chip arrays; biosensors
03/17/2005US20050059061 Beta, beta-carotene 15,15'-enzymes, nucleic acid sequences coding therefor and their use
03/17/2005US20050059060 Oligonucleotide for use as gene trapped sequences (GTSs) and tools in detection and recovery of novel genes; genetic engineering and gene expression analysis; genomics; forensic analysis
03/17/2005US20050059059 Novel nucleic acid based steganography system and application thereof
03/17/2005US20050059058 Oligonucleotide sequences coding integral membrane proteins (ZIPA) for use as tool in identifying bactericidal agents; microbiocides; drug screening
03/17/2005US20050059057 Method of parallel screening for insertion mutants and a kit to perform this method
03/17/2005US20050059055 Using constituent residues to estimate polymer surface areas in pairwise manner; calculate single-residue and pair-residue areas, determine exposed and buried areas by monitoring combinations of single and pair residue areas; protein modeling
03/17/2005US20050059049 Oligonucleotide sequences comprising single-stranded target-binding segment and regions of dyad symmetry for use diagnostic tools in genomic analysis
03/17/2005US20050059048 Methods and compositions for whole genome amplification and genotyping
03/17/2005US20050059046 Methods and systems for the analysis of biological sequence data
03/17/2005US20050059045 Labraries of optimized cytochrome P450 enzymes and the optimized P450 enzymes
03/17/2005US20050059044 Small interfering RNA sequences for use as gene silencing tools; gene expression inhibition
03/17/2005US20050059042 Colorimetric and fluorescent methods for sensing of oligonucleotides
03/17/2005US20050059039 Method for introducing conjugated caps into molecule fragments and systems and methods for using the same to determine inter-molecular interaction energies
03/17/2005US20050059038 Screening mixture and identifying modulators for treatment and prevention of cell proliferative, nervous system, inflammatory and eating disorders
03/17/2005US20050059037 Undergoing a change in the fluorescent signal intensity depending on the corresponding base type in the partner strand with which the single-stranded sequence is hybridized
03/17/2005US20050059035 Nucleotide sequences coding cystic fibrosis transmembrane conductance regulator (CFTR) protein for use in diagnosis prevention and treatment of respiratory system, pulmonary and pancreatic disorders
03/17/2005US20050059034 Isolating bodiliy fluid, recovering genetic materials and screening for genetic disorders; restriction fragment length polymorphism; genetic diagnostic testing; genomic analysis; genetic mapping; bioinformatics
03/17/2005US20050059033 Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
03/17/2005US20050059032 Using polymorphism present in a cardiac potassium channel gene sequences as diagnostic indicator of cardiovascular disorder
03/17/2005US20050059030 Using oligonucleotide probes comprising ribosomal sequence as tool in detection of methicillin resistant strains of bacteria; single nucleotide polymorphism
03/17/2005US20050059028 RNAi-based sensors, caged interfering RNAs, and methods of use thereof
03/17/2005US20050059027 Apparatus and method for separating ribonucleic acid
03/17/2005US20050059023 Methods and kits for monitoring resistance to therapeutic agents
03/17/2005US20050059022 Oligonucleotide sequence comprising two tags (ditag) for use tool in gene discovery and genetic mapping; gene expression analysis; sequencing enhancement
03/17/2005US20050059021 Insulin-like growth factor-1 receptor (IGF-1R) polymorphic alleles and use of the same to identify DNA markers for reproductive longevity
03/17/2005US20050059020 Quantum information processing elements and quantum information processing platforms using such elements
03/17/2005US20050059019 Gene-related RNAi transfection method
03/17/2005US20050059018 Virulence-associated nucleic acids and proteins and uses thereof
03/17/2005US20050059016 Structural motifs and oligomeric compounds and their use in gene modulation
03/17/2005US20050059015 A nucleotide sequence and a complement used to screen, diagnose and monitor individuals for obesity and/or diabetes by detecting the presence, absence, or quantity of a translation product of a transcript having a sequence selected from the group of amino acid sequences; antidiabetic agents
03/17/2005US20050059014 Using multilayered/graded evanescent field sensor platform for monitoring binding activity of biolpolymers; gene expression analysis; pathogen detection
03/17/2005US20050059013 Use of biomarkers for detecting ovarian cancer
03/17/2005US20050059012 Using human epithelial membrane protein 1 sequences as diagnostic tool in detection cell proliferative disorders and antitumor resistant genic variation
03/17/2005US20050059011 Amplification and overexpression of oncogenes
03/17/2005US20050059010 Macular degeneration diagnostics and therapeutics
03/17/2005US20050059009 Using iodophor conjugated nucleotide sequences as diagnostic tool in detection of preferential nucleotide sequences in sample; gene expression analysis
03/17/2005US20050059008 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
03/17/2005US20050059007 Using microarray comprising four immobilzed nucleotide sequences to identify variations associated with glucose transport protein expression; using polymorphic expression to diagnose diabetes
03/17/2005US20050059006 Using presence of polymorphism in ciliary neurotrophic factor (CNTF) gene sequences as diagnostic indicator for lloperidone treatment of psychotic disorders
03/17/2005US20050059005 Microrna molecules
03/17/2005US20050059004 Nucleotide sequences coding translational regulatory element comprising adenine rich regions for use in activation of cap-independent translation of a nucleotide sequence of interest in eukaryotic cells or organisms; translation and heterologous gene expression
03/17/2005US20050059003 Nucleic and amplification methods
03/17/2005US20050059000 Method of stabilizing reagent for amplifying or detecting nucleic acid and storage method
03/17/2005US20050058999 Gene involved in apoptosis regulation
03/17/2005US20050058998 Amino acid and nucleic acid sequences of cyclic nucleotide phosphodiesterases that are involved in T cell activation and may be used in the diagnosis and treatment of disorders such as autoimmune diseases
03/17/2005US20050058995 Primers for use in detecting beta-lactamases
03/17/2005US20050058993 Method and device for detecting feline immunodeficiency virus
03/17/2005US20050058992 Method and device for detecting feline immunodeficiency virus
03/17/2005US20050058991 Methods and compositions for inhibiting herpesviral replication
03/17/2005US20050058990 Apparatus which utilizes patch clamp system to monitor ionic mobility through transport or pore forming proteins; drug screening; anti-hypertension drugs; antiepileptic compounds
03/17/2005US20050058987 Reverse genetics system for screening viricides; immunotherapy
03/17/2005US20050058986 Detection of microbiological growth
03/17/2005US20050058985 Method and kit for identifying vancomycin-resistant enterococcus
03/17/2005US20050058984 Novel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
03/17/2005US20050058983 Immunoglobulin which specifically binds to lymphadenopathy associated viral glycoprotein 120 for use as tool in prevention and treatment of viral infection; immunotherapy
03/17/2005US20050058981 Using nested amplification to identify variation in lymphadenoapthy associated viral polymerase gene sequences; viricides
03/17/2005US20050058665 Genetic engineering of a cell-free mixture with Dna segment linked to promoter for binding and detection with reporter genes for treatment of diptheria
03/17/2005US20050058662 Novel type III secretion pathway in Aeromonas salmonicida, and uses therefor
03/17/2005US20050058661 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus Borrelia
03/17/2005US20050058660 Novel surface antigen
03/17/2005US20050058655 Vaccine and kit for viral disease in swine and diagnosis of diseases